Showing results (131-140 of 146) with videos related to
Sort By:
Pageof 15
Heliyon|April 9, 2025
Corrigendum to "Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients" [Heliyon Volume 10, Issue 13, July 15, 2024, Article e33231]Quentin Philippot, Blandine Rammaert, Gaëlle Dauriat, et al.JAMA|October 3, 2019
Effect of Postextubation High-Flow Nasal Oxygen With Noninvasive Ventilation vs High-Flow Nasal Oxygen Alone on Reintubation Among Patients at High Risk of Extubation Failure: A Randomized Clinical TrialArnaud W Thille, Grégoire Muller, Arnaud Gacouin, et al.Lancet (London, England)|January 22, 2022
A three-step support strategy for relatives of patients dying in the intensive care unit: a cluster randomised trialNancy Kentish-Barnes, Sylvie Chevret, Sandrine Valade, et al.Heliyon|July 22, 2024
Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatientsQuentin Philippot, Blandine Rammaert, Gaëlle Dauriat, et al.Intensive Care Medicine|September 27, 2017
Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort studyElie Azoulay, Peter Pickkers, Marcio Soares, et al.The New England Journal of Medicine|March 21, 2023
Hydrocortisone in Severe Community-Acquired PneumoniaPierre-François Dequin, Ferhat Meziani, Jean-Pierre Quenot, et al.Critical Care (London, England)|May 4, 2019
Influenza and associated co-infections in critically ill immunosuppressed patientsIgnacio Martin-Loeches, Virginie Lemiale, Pierce Geoghegan, et al.JAMA Network Open|September 18, 2025
Outcomes of Critically Ill Adult Patients With Acute EncephalitisRomain Sonneville, Camille Couffignal, Bertrand Souweine, et al.Journal of Critical Care|June 29, 2025
Sex-based differences in ICU management and outcomes of immunocompromised patients: A post hoc analysis of the prospective multicenter multinational Efraim cohortSangeeta Mehta, Elie Azoulay, Laveena Munshi, et al.The European Respiratory Journal|October 13, 2022
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)Jatin Patel, Damon Bass, Albertus Beishuizen, et al.Pageof 15